AIM: Acupuncture for Infectious Mononucleosis Trial
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate feasibility issues related to conducting an acupuncture study in a population of adolescents and young adults with infectious mononucleosis. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2/Phase 3 |
Detailed Description
This study examines the feasibility of treating adolescents and young adults diagnosed with infectious mononucleosis with acupuncture. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Acupuncture Traditional Chinese acupuncture in conjunction with standard medical care |
Procedure: traditional Chinese acupuncture
10 treatments over 6 weeks
|
Active Comparator: Standard medical care standard medical care |
Other: standard medical care
standard care as provided by primary physician
|
Outcome Measures
Primary Outcome Measures
- Chalder Fatigue Questionnaire [12 weeks]
Secondary Outcome Measures
- MOS SF-36 [12 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
mono diagnosis confirmed by lab test
-
21 days or less between start of symptoms and diagnostic test
-
presence of fatigue of at least 4/11 (by Chalder Fatigue Questionnaire)
-
no other illnesses present
-
meets residency requirement
Exclusion Criteria:
-
insufficient communication in English
-
unable to begin acupuncture within 21 days of diagnostic test
-
acupuncture use currently or in the preceding 3 months
-
currently under the care of a TCM practitioner
-
unwilling to be randomized
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Alberta | Edmonton | Alberta | Canada | T6G 2E1 |
Sponsors and Collaborators
- University of Alberta
Investigators
- Principal Investigator: Sunita Vohra, MD, MSc, University of Alberta
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 6866